vs
Encompass Health Corp（EHC）とアンダーアーマー（UAA）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $1.3B、アンダーアーマーの約1.2倍）。Encompass Health Corpの純利益率が高く（9.5% vs -32.4%、差は41.9%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs -5.2%）。アンダーアーマーの直近四半期フリーキャッシュフローが多い（$261.9M vs $116.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs -0.2%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
アンダーアーマー社は米国メリーランド州ボルチモアに本社を置くスポーツウェアメーカーで、高機能なスポーツアパレルやシューズを製造・販売し、世界中のスポーツ愛好家やプロアスリートに品質の高い製品を提供しています。
EHC vs UAA — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $1.3B |
| 純利益 | $146.1M | $-430.8M |
| 粗利率 | — | 44.4% |
| 営業利益率 | 16.7% | -11.3% |
| 純利益率 | 9.5% | -32.4% |
| 売上前年比 | 9.9% | -5.2% |
| 純利益前年比 | 20.8% | -35013.0% |
| EPS（希薄化後） | $1.43 | $-1.01 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.5B | $1.3B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.4B | $1.4B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.3B | $1.3B |
| Q4 25 | $146.1M | $-430.8M | ||
| Q3 25 | $126.5M | $-18.8M | ||
| Q2 25 | $142.1M | $-2.6M | ||
| Q1 25 | $151.5M | $-67.5M | ||
| Q4 24 | $120.9M | $1.2M | ||
| Q3 24 | $108.2M | $170.4M | ||
| Q2 24 | $114.1M | $-305.4M | ||
| Q1 24 | $112.5M | $6.6M |
| Q4 25 | — | 44.4% | ||
| Q3 25 | — | 47.3% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 46.7% | ||
| Q4 24 | — | 47.5% | ||
| Q3 24 | — | 49.8% | ||
| Q2 24 | — | 47.5% | ||
| Q1 24 | — | 45.0% |
| Q4 25 | 16.7% | -11.3% | ||
| Q3 25 | 14.9% | 1.3% | ||
| Q2 25 | 16.2% | 0.3% | ||
| Q1 25 | 16.4% | -6.1% | ||
| Q4 24 | 14.3% | 1.0% | ||
| Q3 24 | 13.6% | 12.4% | ||
| Q2 24 | 14.3% | -25.3% | ||
| Q1 24 | 13.6% | -0.3% |
| Q4 25 | 9.5% | -32.4% | ||
| Q3 25 | 8.6% | -1.4% | ||
| Q2 25 | 9.7% | -0.2% | ||
| Q1 25 | 10.4% | -5.7% | ||
| Q4 24 | 8.6% | 0.1% | ||
| Q3 24 | 8.0% | 12.2% | ||
| Q2 24 | 8.8% | -25.8% | ||
| Q1 24 | 8.5% | 0.5% |
| Q4 25 | $1.43 | $-1.01 | ||
| Q3 25 | $1.24 | $-0.04 | ||
| Q2 25 | $1.39 | $-0.01 | ||
| Q1 25 | $1.48 | $-0.16 | ||
| Q4 24 | $1.18 | $0.00 | ||
| Q3 24 | $1.06 | $0.39 | ||
| Q2 24 | $1.12 | $-0.70 | ||
| Q1 24 | $1.10 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $464.6M |
| 総負債低いほど良い | $2.4B | $989.7M |
| 株主資本純資産 | $2.4B | $1.4B |
| 総資産 | $7.1B | $4.6B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | 0.69× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $464.6M | ||
| Q3 25 | $48.7M | $396.0M | ||
| Q2 25 | $99.1M | $911.0M | ||
| Q1 25 | $95.8M | $501.4M | ||
| Q4 24 | $85.4M | $726.9M | ||
| Q3 24 | $147.8M | $530.7M | ||
| Q2 24 | $154.4M | $884.6M | ||
| Q1 24 | $134.4M | $858.7M |
| Q4 25 | $2.4B | $989.7M | ||
| Q3 25 | $2.4B | $1.2B | ||
| Q2 25 | $2.3B | $989.2M | ||
| Q1 25 | $2.3B | $595.1M | ||
| Q4 24 | $2.4B | $595.2M | ||
| Q3 24 | $2.3B | $594.6M | ||
| Q2 24 | $2.7B | $595.4M | ||
| Q1 24 | $2.7B | $675.8M |
| Q4 25 | $2.4B | $1.4B | ||
| Q3 25 | $2.4B | $1.9B | ||
| Q2 25 | $2.3B | $1.9B | ||
| Q1 25 | $2.2B | $1.9B | ||
| Q4 24 | $2.1B | $2.0B | ||
| Q3 24 | $2.0B | $2.0B | ||
| Q2 24 | $1.8B | $1.8B | ||
| Q1 24 | $1.7B | $2.2B |
| Q4 25 | $7.1B | $4.6B | ||
| Q3 25 | $6.9B | $4.9B | ||
| Q2 25 | $6.8B | $4.9B | ||
| Q1 25 | $6.6B | $4.3B | ||
| Q4 24 | $6.5B | $4.6B | ||
| Q3 24 | $6.5B | $4.5B | ||
| Q2 24 | $6.4B | $4.9B | ||
| Q1 24 | $6.2B | $4.8B |
| Q4 25 | 1.00× | 0.69× | ||
| Q3 25 | 1.01× | 0.64× | ||
| Q2 25 | 1.02× | 0.53× | ||
| Q1 25 | 1.08× | 0.31× | ||
| Q4 24 | 1.14× | 0.30× | ||
| Q3 24 | 1.20× | 0.30× | ||
| Q2 24 | 1.46× | 0.33× | ||
| Q1 24 | 1.54× | 0.31× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $278.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $261.9M |
| FCFマージンFCF / 売上 | 7.6% | 19.7% |
| 設備投資強度設備投資 / 売上 | 14.8% | 1.2% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | — |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $-45.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $278.1M | ||
| Q3 25 | $270.8M | $-69.8M | ||
| Q2 25 | $270.2M | $48.9M | ||
| Q1 25 | $288.6M | $-202.2M | ||
| Q4 24 | $278.8M | $311.3M | ||
| Q3 24 | $267.8M | $-321.4M | ||
| Q2 24 | $217.4M | $153.0M | ||
| Q1 24 | $238.8M | $-122.9M |
| Q4 25 | $116.7M | $261.9M | ||
| Q3 25 | $83.7M | $-90.3M | ||
| Q2 25 | $113.3M | $13.5M | ||
| Q1 25 | $125.5M | $-231.0M | ||
| Q4 24 | $80.1M | $262.9M | ||
| Q3 24 | $120.3M | $-367.2M | ||
| Q2 24 | $60.5M | $107.3M | ||
| Q1 24 | $99.4M | $-156.7M |
| Q4 25 | 7.6% | 19.7% | ||
| Q3 25 | 5.7% | -6.8% | ||
| Q2 25 | 7.8% | 1.2% | ||
| Q1 25 | 8.6% | -19.6% | ||
| Q4 24 | 5.7% | 18.8% | ||
| Q3 24 | 8.9% | -26.2% | ||
| Q2 24 | 4.6% | 9.1% | ||
| Q1 24 | 7.6% | -11.8% |
| Q4 25 | 14.8% | 1.2% | ||
| Q3 25 | 12.7% | 1.5% | ||
| Q2 25 | 10.8% | 3.1% | ||
| Q1 25 | 11.2% | 2.4% | ||
| Q4 24 | 14.1% | 3.5% | ||
| Q3 24 | 10.9% | 3.3% | ||
| Q2 24 | 12.1% | 3.9% | ||
| Q1 24 | 10.6% | 2.5% |
| Q4 25 | 2.37× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.90× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 2.31× | 252.26× | ||
| Q3 24 | 2.48× | -1.89× | ||
| Q2 24 | 1.91× | — | ||
| Q1 24 | 2.12× | -18.71× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
UAA
| Apparel | $934.0M | 70% |
| Footwear | $265.1M | 20% |
| Accessories | $107.7M | 8% |
| License | $27.2M | 2% |
